Compare UTHR & CW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. Most of the company's sales are generated within the United States. United Therapeutics also markets a pediatric oncology drug, but its focus largely remains in pulmonary arterial hypertension.
Curtiss-Wright Corporation delivers engineered products and services to commercial, defence, power generation, and other industrial markets. It offers industrial vehicle components, control systems and weapons handling systems, pumps, valves, and other solutions. The diversified global company attempts to deliver products on high-performance platforms that require technical sophistication. It has three operating segments based on the markets serviced: Naval & Power which provides coolant pumps, power-dense compact motors, generators, secondary propulsion systems, pumps, pump seals, valves, control rod drive mechanisms, and fastening systems also generate the majority of revenue for the company; Its others segments are Aerospace & Industrial and Defense Electronics.